Skip to main navigation

Skip to Content

Investors & Media Contact Us LinkedIn Twitter

About Us
- Discover Karuna
- Leadership
Our Focus
- Schizophrenia
- Psychosis in Alzheimer’s Disease
Pipeline & Programs
Patient Resources
Culture & Careers

SEC Filing Details

Overview
Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Investor Resources
Media Kit

SEC Filing Details

Document Details

Form

Filing Date

Feb 23, 2023

Document Date

Dec 31, 2022

Form Description

Annual report which provides a comprehensive overview of the company for the past year

Filing Group

Annual Filings

Company

Karuna Therapeutics

Issuer

Karuna Therapeutics, Inc.

Filing Formats

iXBRL

View HTML

XBRL

XBRL Viewer

EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT

EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT

EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT

EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

XML - XBRL INSTANCE DOCUMENT

Print Page Email Page RSS Feeds Email Alerts

About Us
Our Focus
Pipeline & Programs
Patient Resources
Culture & Careers
Investors & Media
Contact Us

Connect with us on LinkedIn Twitter

Copyright 2023 Karuna Therapeutics™. All Rights Reserved. Privacy Policy. Terms of Use. Social Media Community Guidelines.

Top